Macula Vision Systems
Macula Vision Systems develops Epsilon, an automated computational microscopy platform that uses software-defined image reconstruction and AI diagnostics to replace precision optics for clinical laboratories serving community labs, reference labs, point-of-care, and academic medical centers.
- Company typePrivate
- Founded2021
- HeadquartersTucson, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Macula Vision Systems does
Macula Vision Systems is a privately held, early-stage developer of automated computational microscopy systems for clinical laboratories, founded in 2021 and headquartered at 1800 Innovation Park Dr in Oro Valley, Arizona. The company employs between one and ten people and operates a direct enterprise sales motion targeting lab directors, pathologists, researchers, lab technicians, IT/engineering, and procurement professionals through its product website. It is a member of the NVIDIA Inception Program for AI startups and has secured small early-stage financing from Brooks Hill Partners plus Arizona-based awards.
The company's core product, Epsilon, is a software-defined microscopy platform that replaces precision optical components with low-cost sensor arrays combined with computational imaging algorithms. The architecture comprises five proprietary building blocks: computational imaging (algorithms that reconstruct high-resolution images from raw sensor data without precision lenses), AI-driven automated diagnostics (assisted or fully automated interpretation), a solid-state design with no moving optical parts, an on-device clinical archive storing every scan with full metadata, and a software-defined platform enabling new assays and analysis pipelines to be deployed via software updates. Target use cases span community and regional clinical labs, high-volume reference laboratories, point-of-care and field settings, and hospital and academic medical centers.
Macula's revenue model is built around instrument hardware sales complemented by recurring software subscriptions enabled by the platform's software-defined assay updates, plus professional services for integration and demonstration. Pricing is not publicly disclosed and is quote-based, requiring direct inquiry through a sales contact form. The website supports demo requests, pricing information requests, technical integration discussions, and partnership inquiries. Total disclosed funding is approximately $180,000 across three small rounds, and there are no named customers, no disclosed revenue, no management team bios, no patents, and no regulatory certifications in the input.
Macula Vision Systems firmographics
Firmographics- Name
- Macula Vision Systems
- Legal name
- Macula Vision Systems
- Website
- https://macula-vision.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Macula Vision Systems develops Epsilon, an automated computational microscopy platform that uses software-defined image reconstruction and AI diagnostics to replace precision optics for clinical laboratories serving community labs, reference labs, point-of-care, and academic medical centers.
- Ownership category
- akta.pro rank
Macula Vision Systems industry classification
Industry- Product category
- Clinical Microscopy Instruments
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Medical Imaging AI (HDAAAEAH)
- akta.pro secondary industries
- Machine Vision & Optical Sensing (Cameras, 3D vision, LiDAR, illumination) (IMAGAFAB), Lab Middleware, Instrument Connectivity & Automation (HLACAMAI)
Keywords
Where Macula Vision Systems is headquartered
LocationHeadquarters
- HQ city
- Tucson
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Macula Vision Systems business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
Revenue model
- Instrument Hardware Sales: Sale of automated microscopy instruments with integrated sensor-illumination arrays for clinical laboratory environments.
- Software Subscriptions: Software-defined platform enables new assays and analysis pipelines deployed via software updates, suggesting recurring software licensing model.
- Professional Services: Product demonstrations, technical integration support, and implementation services offered through direct sales engagement.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels3 records
Macula Vision Systems product offering
Product offeringCore offering
Macula Vision Systems develops and sells Epsilon, an automated computational microscopy instrument for clinical laboratories. The platform replaces complex precision optics with low-cost sensor arrays and software algorithms that reconstruct high-resolution digital images and run AI-powered diagnostics. The solid-state instrument operates without manual focusing, enabling affordable, automated microscopy for community labs, high-volume reference labs, point-of-care settings, and hospital/academic centers.
Product overview
Macula Vision Systems offers a unified computational microscopy platform called Epsilon, designed for automated clinical microscopy. The platform integrates computational imaging, automated AI diagnostics, and solid-state hardware into a single instrument. Key capabilities include: computational imaging (software algorithms reconstruct high-resolution images from sensor data), automated diagnostics (AI-powered assisted or fully automated interpretation), integrated data storage (on-device clinical archive with full metadata), and software-defined functionality (new assays deployable via software updates). The platform targets community clinical labs, high-volume reference labs, point-of-care settings, and hospital/academic centers.
Differentiator
Problem solved
Functional benefit
Products and services
- Epsilon
Companies that use Macula Vision Systems
Customer profileSegments4 records
Ideal customer profiles4 records
Macula Vision Systems technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature5 records
Macula Vision Systems partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- NVIDIAcoreMacula Vision Systems is a member of the NVIDIA Inception Program, an acceleration platform for AI startups. This partnership provides access to NVIDIA's technical resources, developer tools, and ecosystem support for AI-driven computational imaging technology development.
Scale indicators2 records
Recent moves3 records
Expansion highlights4 records
Macula Vision Systems competitors and assessment
Company assessmentDirect peers
- Scopio Labs: Scopio Labs develops fully digital, AI-powered cell morphology systems for hematology laboratories. It is the closest direct peer to Macula's Epsilon platform - both deliver computational microscopy for clinical labs, both replace manual slide review with software-defined workflows.
- Nanolive: Nanolive builds label-free, computational live-cell imaging using holotomographic microscopy paired with AI-driven image reconstruction. Like Macula, it replaces complex optics with software/sensor-based reconstruction and targets research and clinical users.
Emerging players
- PathAI: PathAI applies deep learning to pathology and digital slide analysis for clinical and biopharma applications. It is an adjacent AI-imaging peer serving overlapping clinical lab buyer personas (pathologists, lab directors) and competing for the same diagnostics AI dollar.
- Proscia: Proscia offers a digital pathology platform with AI-powered image analysis and enterprise pathology workflows. It targets pathology labs with software-managed slide review - a similar software-defined imaging shift to Macula's instrument-side approach.
- Akoya Biosciences: Akoya Biosciences builds spatial biology and tissue imaging platforms used in clinical and research pathology. It is comparable as an AI-enabled tissue/cell imaging instrumentation vendor targeting academic centers and clinical labs.
- Ibex Medical Analytics: Ibex develops AI algorithms for digital pathology that assist pathologists in cancer diagnosis. It competes for the same clinical lab AI budget and shares the "AI replaces manual image interpretation" value proposition as Macula.
- RareCyte: RareCyte develops imaging-based liquid biopsy and cell analysis platforms combining proprietary instrumentation with AI-driven cell identification. It is comparable as an AI-enabled clinical cell imaging company targeting reference labs and research customers.
Broad incumbents
- Hamamatsu Photonics: Hamamatsu is a major supplier of optical sensors, cameras, and whole-slide imaging systems used in clinical microscopy and digital pathology. It is a broad incumbent whose precision-optics-and-sensor stack Macula seeks to disrupt.
- Leica Biosystems: Leica Biosystems (Danaher) is a leading provider of histopathology instruments, slide scanners, and staining systems used in clinical labs globally. It represents the traditional optics-and-reagent workflow Macula is attempting to supplant.
- Roche Diagnostics (Ventana): Roche's Ventana division dominates automated clinical staining and digital pathology in high-volume reference labs. It is the most entrenched incumbent Macula must displace in its primary reference-lab target segment.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Macula Vision Systems social profiles
Digital presenceMacula Vision Systems financial estimates
Financial estimateRevenue estimate
Valuation estimate
Macula Vision Systems leadership team
Management profileNumber of profiles
Profiles1 record
Macula Vision Systems funding detail
Funding detailFunding overview
Funding rounds3 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Macula Vision Systems M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Macula Vision Systems
What does Macula Vision Systems do?
Macula Vision Systems develops and sells Epsilon, an automated computational microscopy instrument for clinical laboratories. The platform replaces complex precision optics with low-cost sensor arrays and software algorithms that reconstruct high-resolution digital images and run AI-powered diagnostics. The solid-state instrument operates without manual focusing, enabling affordable, automated microscopy for community labs, high-volume reference labs, point-of-care settings, and hospital/academic centers.
Is Macula Vision Systems a public or private company?
Macula Vision Systems is a private company. It is classified as venture growth investor backed and is currently operating.
When was Macula Vision Systems founded?
Macula Vision Systems was founded in 2021. It employs 1 to 10 people.
Where is Macula Vision Systems based?
Macula Vision Systems is headquartered in Tucson, United States, in the North America region.
How does Macula Vision Systems make money?
Three revenue lines are on record. Instrument Hardware Sales are the primary driver. The others are software Subscriptions and professional Services.
Who are Macula Vision Systems's main competitors?
Direct peers on record are Scopio Labs and Nanolive. Emerging players are PathAI, Proscia, Akoya Biosciences, Ibex Medical Analytics and RareCyte. Broad incumbents are Hamamatsu Photonics, Leica Biosystems and Roche Diagnostics (Ventana).
Does Macula Vision Systems have an API?
No public API is recorded for Macula Vision Systems.
What industry is Macula Vision Systems in?
Macula Vision Systems's product category is Clinical Microscopy Instruments. Its primary akta.pro industry code is HDAAAEAH, Medical Imaging AI, with a secondary code of IMAGAFAB, Machine Vision & Optical Sensing (Cameras, 3D vision, LiDAR, illumination). Its NAICS code is 334516 and its SIC code is 3841.